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Abstract
Malnutrition through excessive food consumption is a worldwide pandemic. 
Changes in lifestyle, diet and physical activity have resulted in an exponential 
increase in the number of obese people around the world. Multiple factors influence 
the development of this disease, and recently it has been suggested that gut micro-
biota (GM) plays an important role in nutrient absorption and energy regulation 
of individuals, thus affecting their nutritional status. It has been proven that gut 
microbiota is different in individuals with a normal nutritional status compared 
to those who are obese. Therefore, to study bacterial populations that make up the 
microbiota and to understand how prebiotics and probiotics affect the increase 
of these bacteria has become a promising alternative to treat obesity. This chapter 
looks at defining the established relationship between probiotics, prebiotics and gut 
microbiota that develop in obese people and people of normal weight, with the aim 
of providing future dietary recommendations to treat this medical condition.
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1. Introduction
Currently, obesity is defined as a medical condition characterised by an energy 
imbalance as a consequence of energy intake bigger than energy expenditure [1]. 
The US Centers for Disease Control and Prevention (CDC) defines it as ‘excessive 
weight that is considered unhealthy for a given height’. It was not until 1997 that the 
World Health Organization (WHO) described obesity as an excessive accumulation 
of body fat that can be harmful to people’s health [2].
One of the criteria to diagnose obesity is through the calculation of body mass 
index (BMI); the result, according to the WHO, must be equal to or bigger than 
30 kg/m2 [2].
However, the Asian population including Korea, given their increased risk of 
developing comorbidities, such as cardiovascular diseases and type 2 diabetes, 
agreed to an overweight category with a BMI between 23 and 24.9 kg/m2 and 
obesity with a BMI > 25 kg/m2 (Table 1) [3].
Worldwide obesity is a public health problem, and despite all the strategies 
designed and implemented to reverse the situation, these have not been effec-
tive. According to the World Health Organization, globally, in 2016, more than 
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1900 million adults were overweight, over 650 million were obese, and 41 million 
children under the age of 5 were overweight. Fifty-seven percent of the world’s 
population lives in countries where being overweight and obesity cause more deaths 
than being underweight. Furthermore, each year at least 2.8 million people die 
worldwide due to obesity or being overweight, irrespective of whether the country 
is economically developed or not [1, 2].
Various studies have shown that patients with illnesses related to the gastroin-
testinal tract, such as type 2 diabetes, obesity and cardiovascular diseases, among 
others, present dysbiosis or an imbalance within the gut microbiota (GM).
A hypothesis of the positive influence of microbiota on fat storage exists, and 
several studies carried out in mice have proven the role of certain fatty acids in the 
diet in the prevention of obesity, an effect mediated through changes in the compo-
sition of gut microbiota. Studies in humans have also shown a relationship between 
a decrease in Bacteroidetes in obese individuals and a greater proportion of these in 
the faecal microbiota in subjects who have undergone hypocaloric diets and who 
have managed to reduce their weight [5, 7].
An important role of the regulation of gut microbiota has been proven as the 
ingestion in the diet of prebiotics and probiotics that modulate the growth of 
diverse families of bacteria that could influence the nutritional status of individuals.
2. Obesity as a multifactorial condition
Obesity is a medical condition of multifactorial causes, ranging from the influ-
ence of the nearby environment on the acquisition of predisposing habits, such 
as the consumption of foods high in refined carbohydrates and saturated fats and 
a sedentary lifestyle. Genetic predispositions are also among the principle causes 
[5]. On the other hand, socioeconomic development, transport, urban planning, 
environmental, agricultural, educational, processing, distribution and marketing 
policies on food influence dietary habits and preferences, as well as people’s level of 
physical activity [5, 6].
Research concludes that obesity occurs with greater prevalence in women, older 
people (25 years and above), those with a lower school level and those with a low 
socioeconomic income. Geographic location also has an influence, but it occurs in an 
opposite way in men and women. There is greater obesity in women living in rural 
areas, but in men rurality is a protective factor since obesity is more prevalent in those 
living in urban areas. This is most likely explained by the higher levels of physical 
activity of men living in rural areas [6]. In terms of lifestyles, obese people have lower 
levels of physical activity, a bigger consumption of salt and low levels of sleep [7].
Another bibliographical review relates meal times with the prevalence of 
obesity. This study, which is based on an analysis of the circadian rhythm, a biologi-
cal function regulated by the anterior hypothalamus, reveals clinical observations 
WHO (BMI) Asia-Pacific (BMI)
Underweight <18.5 <18.5
Normal 18.5–24.9 18.5–22.9
Overweight 25–29.9 23–24.9
Obese ≥30 ≥25
Table 1. 
Comparison of the World Health Organization (WHO) and Asia-Pacific body mass index (BMI) 
classifications in COPD patients [3].
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and experiments on animals that relate the times of food intake to metabolism and 
body weight. It is proposed that eating at times when the body is prepared for rest 
increases body weight. At rest there are low levels of hormonal activity, a low body 
temperature and low activity of nutrient absorption which alters energy homeosta-
sis and facilitates the accumulation of energy, increasing body weight [5, 8].
A factor recently studied as a cause of obesity is gut microbiota, defined as the 
communities of living microorganisms that colonise the intestines. It is known 
that the gut microbiota contributes significantly to the two main functions of the 
gastrointestinal tract: nutrition and defence.
3. Human gut microbiota: role in people’s health
The human gut is colonised by an enormous quantity of communities of living 
microorganisms, mainly bacteria that form the GM. As well as participating in 
processes of digestion and absorption of nutrients, the homeostasis of GM has been 
linked to beneficial health effects [9].
In the womb, the intestine of the human foetus is sterile, and it is after birth 
when the newborn acquires its gut microbiota. From birth, several factors influ-
ence the composition and initial colonisation of the GM. Natural labour favours the 
rapid settlement of bacteria that come from the vaginal and faecal microbiota of 
the mother, associated with a low risk of suffering from diseases and some types of 
malnutrition through excessive food consumption in the future. On the other hand, 
children born through caesarean section have a slower colonisation of bacteria, 
mainly from the hospital environment and healthcare professionals who are in con-
tact with the child. It must be considered that the time taken to establish the GM is a 
risk factor for the colonisation of Clostridium. Despite the fact that GM is established 
from birth, its colonisation continues to vary, given that there are diverse factors that 
influence its composition: nutrition, exclusively or predominantly breastfeeding, 
age, geographic location and intake of supplements and medicines [9, 10].
In the first years of life, when nutrition is acquired through breastfeeding or 
formula milk, GM is mostly populated by bifidobacteria. This is highly adapted to 
processing oligosaccharides in milk. Later, reaching adulthood, the GM is made 
up of two main families of bacteria: Firmicutes and Bacteroidetes. Firmicutes are the 
family found in greater proportion, including more than 200 genders, and the most 
important are Mycoplasma, Bacillus and Clostridium. Once these are established in 
adulthood, they remain stable in the individual (Figure 1) [11–14].
Various studies support the fact that variations in people’s health status are 
directly related to functions of the GM, highlighting its effect on the immune 
response, nutrition and metabolism [15].
The immune tissues of the gastrointestinal tract make up the most complex and 
largest proportion of the body’s immune system, which is why alterations of GM 
are caused by disequilibrium of the immune system, such as the development of 
allergies and autoimmune diseases [16].
There is a complex interaction between the microbiota, the intestinal epithelium 
and the gastrointestinal immune system, with many metabolites and microbial 
components that have a direct influence on the host immunity. The production of 
metabolites from nutrients or the modification of the metabolites produced by the 
host has a direct effect on the immune cells and on the integrity and permeability of 
the intestinal epithelium. The enteric immune system is constantly evaluating and 
responding to the gut microbiota [17].
Nutritional and metabolic functions of GM involve the synthesis of certain 
vitamins such as K, B12, biotin, folic acid and pantothenic acid, as well as the 
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fermentation of non-digestible carbohydrates, polysaccharides and oligosaccha-
rides. It makes up an important source of energy for bacterial proliferation and 
produces short-chain fatty acids that the host can absorb, favouring the recovery 
and absorption of ions such as calcium, iron and magnesium [18].
As well as the principal functions of GM, recent studies have associated it with 
the development of obesity and chronic diseases. In order to avoid such conditions, 
it has been proposed that the role of prebiotics and probiotics in the maintenance of 
the nutritional status and prevention of diseases should be studied [4].
Undoubtedly, microorganisms present in the guts are fundamental throughout 
life as they have a direct relationship with health and illness. It is vital to take special 
care in the factors that make up the initial GM as it is responsible for the general 
status of future health of individuals.
4. Microbiota and its role in obesity and chronic diseases
As already described, the gut microbiota is made up of a diversity of pathogens 
which highlights the presence of Gram-negative or Gram-positive bacteria. The 
equilibrium of this ecosystem provides us great health benefits, in the absorption 
and digestion of nutrients, as well as influencing immune function [4–18].
In recent years, the prevalence of non-transmittable chronic diseases has 
increased, which has led different researchers to address the different risk factors 
related to the appearance of those that have been mentioned and the direct risk 
between microbiota and diseases [18].
Studies linked to the establishment of microbiota with chronic diseases have 
described that this stability of original microbiota is affected by diverse factors 
among which the macro- or micronutrients and dietary patterns are mentioned [18].
When the balance of microbiota is altered by a factor, whether it is the use of 
antibiotics, stress or diet with an increased consumption of fats, carbohydrates and 
fibre, it will have an effect on health. It has also been mentioned that abundance 
or scarcity of food, environmental pollution, chronic stress and food such as dairy 
products, sugars, coffee, tea and alcohol, among others, affects the intestinal 
mucous membrane and, consequently, changes the stability and mode of action of 
the microbiota [19].
All these factors cause an alteration in microbiota where the equilibrium of 
two large families of bacteria is affected: Bacteroidetes and Firmicutes. In a study 
carried out on the composition of the microbiota of obese mice, it was shown that 
they had increased concentrations of Firmicutes by more than 50%, while those of 
Bacteroidetes decreased correlatively [20].
Figure 1. 
Factors that influence the initial colonisation of gut microbiota.
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In order to demonstrate that the microbiota changes through time, a study 
was carried out where old teeth found in skeletons in different periods of history 
were analysed. It was found that microbial changes are linked to human evolution 
from the hunter-gatherer period to the industrial revolution, due to the increased 
consumption of processed foods. These conclusions support the idea that diet and 
the type of food alter human microbiota [18].
Turnbaugh et al. carried out studies on ‘humanised’ or sterile mice models to 
which human faecal matter was transplanted and the microbiota was analysed once 
they were fed with a Western diet rich in fats and sugars. They found a presence of 
greater adiposity and a reduced proportion of Bacteroidetes than Firmicutes in the 
faecal microbiota of these mice [19].
There is a direct relationship between microbiota and energy uptake and 
consequently a relationship with the onset of obesity. This has been supported by 
a study in obese children, which showed a microbiota rich in Enterobacteriaceae, 
low in Bacteroidetes and increased in Firmicutes. When the children were subjected 
to diets with low carbohydrate and fat content, the composition of the microbiota 
changed [18].
Other studies carried out in mice reflect the relationship between energy bal-
ance, diet and microbiota. The transplantation of the obese microbiota results in an 
increase of adiposity in the recipients, which shows that microbiota affects nutrient 
acquisition, energy storage and consequently the development of obesity [18, 22].
Jumpertz et al. carried out studies on the GM of obese and slim patients. They 
were given caloric diets, and their stools were analysed by measuring calories 
ingested and those eliminated in the faeces using a bomb calorimeter. This study 
concluded that there are changes in the GM where there are increases in energy 
storage, a decrease in the Bacteroidetes and an increase in the Firmicutes bacteria. All 
these changes could explain the variation of the uptake of energy in individuals and 
therefore a relationship with the predisposition to obtain metabolic disorders [18].
According to the above, the instability of the GM or changes in the original GM 
affects the metabolism of the whole organism. Recent studies have shown that the 
increase of bile acids in the intestine when comparing sterile rats with normal rats 
would show that the GM is not only related with obesity but also with a diverse 
range of metabolic diseases [21].
When transplanting GM into obese mice, the new term obesogenic microbiota 
was determined, associated with an increase in hepatic glucose production and 
promotion of triglyceride deposits. These studies show that there is an increase in 
TNF pro-inflammatory cytokines which can cause insulin resistance. This can be 
correlated with the appearance of DM-OB, since its presence has been proven to be 
directly related to the presence of elevated pro-inflammatory factors [22].
Toll-type receptors are receptors that recognise important patterns within immu-
nity and inflammation processes; they are present in diabetic obese patients with 
metabolic syndrome. In publications made in the Latin American report, they show 
the role of GM with regard to the regulation of these diseases, since the mice deficient 
in Toll-like receptor 5 (TLR5), which recognises microbial patterns, show hyperpha-
gia, become obese and develop characteristics indicative of metabolic syndrome. This 
is also proven when GM from these mice was transplanted into germ-free mice with 
the TLR5 gene—the receptor mice developed characteristics similar to the metabolic 
syndrome. In summary, Larsen et al. demonstrated that GM from diabetic patients 
produced a significant reduction in Firmicutes and Clostridia [22, 23].
When administering antibiotics to these types of obese patients, many Firmicutes 
were eliminated, which resulted in improved insulin and glucose intolerance.
The exact mechanisms by which GM contributes to the development of obesity 
have not been fully elucidated, but it has been suggested that the main ways would 
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include increased lipoprotein lipase (LPL) activity, increased intestinal permeabil-
ity and lipogenesis [20]. Faecal microbiota transplantation studies in both healthy 
individuals and rats to obese receptors have shown the favourable action of the 
GM of the emitters towards the obese individuals, reducing the levels of glycemia, 
preventing the expansion of fat and regulating inflammatory processes. Studies also 
suggest that the reverse mechanism, that is, transplantation of intestinal microbiota 
from obese to healthy individuals, can transmit the development of obesity, assign-
ing GM as a predisposing factor for obesity [17].
Thanks to many randomised studies that have been carried out, it will be pos-
sible to identify the microbiota properties that are contributing to the obesity epi-
demic, diabetes and metabolic diseases. This will in turn allow scientists to extract 
information and characterise diseases with the aim to prevent or cure them [21].
5. Role of prebiotics and probiotics in maintaining nutritional status
Probiotics have been defined by the United Nations’ Food and Agriculture 
Organization (FAO) and the WHO as ‘living microorganisms that provide their host 
with health benefits when consumed in appropriate quantities’ [4].
Prebiotics were defined by Gibson and colleagues in 2004 as ‘ingredients that 
when selectively fermented, give rise to specific changes in gut microbiota com-
position and/or activity, which leads to many health benefits with regard to, for 
example, the wellbeing of individuals’ [24].
According to the preceding analysis, it has been recently established that the 
microbiotics that colonise the human intestine can play an important role in causing 
obesity and developing other metabolic and immunological illnesses within their 
host. This statement is based on recent metagenomic studies that have determined 
that there are differences between obese individuals and those of a normal weight 
in terms of gut microbiota. These differences are associated with the presence of a 
microbial population in obese individuals, which has a greater capacity to recuper-
ate dietary energy and/or favour the onset of chronic low-grade inflammation [25].
Some studies conducted on obese individuals in relation to their prebiotic 
 consumption—capable of selectively stimulating a limited number of gut microbi-
ota genres/species which results in health benefits—have demonstrated results that 
can be categorised by an increasing trend in satiation. This effect has been observed 
with inulin fibre [24].
The mechanisms implicated in satiation following the consumption of oligofruc-
tose and inulin have been associated with intestinal fermentation-induced hydrogen 
formation, which in turn has been correlated with a postprandial increase in 
plasma levels of peptides GLP-1 and PYY, which are involved in energy homeostasis 
through supressing the sensation of hunger (Figure 2) [24].
Studies carried out involving the use of probiotics to control body fat accu-
mulation show promising results, but it is also necessary to carry out further, 
well-designed studies which incorporate randomised, double-blind trials with a 
placebo control, in order to demonstrate the efficacy of specific probiotic strains 
when preventing or treating the overweight and obese. In this sense, it is important 
to highlight that the results obtained in the trials would be specific to the strains 
analysed, meaning it is not possible to extrapolate the results or action mechanisms 
to a species or genre as a whole [4, 24].
Consequently, much remains to be done in this field. However, when putting 
everything in perspective, modulating the composition of gut microbiota using 
probiotics could be considered as a new avenue through which we can treat the 
overweight and obese [24].
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On the other hand, prebiotics promote the absorption of minerals such as 
calcium, magnesium, zinc and iron due to their ability to bind to them. This thereby 
prevents their absorption into the small intestine to reach the colon, where they 
are released and subsequently absorbed. Better calcium absorption is linked to 
prebiotic fermentation caused by gut microbiota, which produces short-chain fatty 
acids and lowers luminal pH, increasing the bioavailability and passive absorption 
of calcium through colonocytes. It has also been proven that calcium bioavailabil-
ity is improved when released through hydrolysis of a compound called ‘calcium 
phytate’, which occurs due to action of bacterial phytases present in the beneficial 
microbiota. It is also improved when calcium becomes more soluble as a result of an 
increase in the volume of water in the colon, caused by the osmotic effect of prebi-
otics. This increase in calcium absorption is beneficial for bone health as it increases 
bone mass and delays the onset of osteoporosis. This is important when considering 
growth periods, during which peak bone mass is reached in postmenopausal women 
and in elderly people [25].
Prebiotics stimulate iron absorption into the colon, by increasing the soluble frac-
tion in the cells. Zinc is necessary for the development and maturation of the skele-
ton, and prebiotics stimulate zinc bioavailability. Therefore, mineral is supplemented 
through the diet. Furthermore, prebiotics are attributed to another set of properties 
related to particular systemic disorders. Prebiotic carbohydrates (GOS, FOS, inulin) 
reduce blood pressure, as well as blood levels of glucose, cholesterol, triglycerides and 
phospholipids, as well as triglyceride and fatty acid synthesis in the liver, minimising 
the risk of developing diabetes, obesity and atherosclerosis [25, 26].
6. Influence of probiotics in the development of obesity
The development of obesity is not caused by one specific factor. On the contrary, 
it is the result of an interaction of genetic, environmental, social, lifestyle factors, 
etc., which transforms it into a multifactorial disorder, which explains how quickly 
it has become more prevalent throughout all age groups in developed countries and 
shows that traditional theories are not adequate to explain the complex phenom-
enon of gaining body weight [27].
In recent decades and as a result of advances in science, research for ‘nontradi-
tional’ etiological factors involved in an individual’s excessive weight gain has begun 
[28]. One of these new factors is highlighted in a study on the role of probiotics and 
their influence on gut microbiota. It should be noted that even now few studies have 
been carried out on humans to elucidate the effect of these microorganisms on body 
Figure 2. 
Mechanisms implicated in the satiety of obese individuals related to inulin consumption.
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weight, and existing studies still show contradictory results; the available literature 
arises from findings found in animals (rats) [4].
However, several ways in which probiotics may influence adiposity and weight 
gain have been identified. These range from extracting calories from nutrients, 
generating specific metabolites, to modulating the behaviour of the brain-intes-
tine axis [27].
These hypotheses arise from research suggesting that obese individuals have a 
different composition of gut microbiota to subjects of a normal weight. For exam-
ple, in people with obesity, they have observed a decrease in members of phylum 
Bacteroidetes (Prevotella and Bacteroides genera) and an increase in members of phy-
lum Firmicutes (Clostridium, Enterococcus, Lactobacillus). It has been suggested that 
the aforementioned microorganisms have a greater capacity to extract energy from 
the undigestible waste products of nutrients that pass through the large intestine. 
These alterations are normalised with both phyla, when the subjects lose weight 
(increase of Bacteroidetes and decrease of Firmicutes) [29]. It has been observed that 
obese and inactive people have greater adiposity and insulin resistance but also less 
diversity and microbial composition (Figure 3) [4].
A study conducted at Laval University in Canada evaluated the effect of 
Lactobacillus rhamnosus probiotic (LRP) supplementation on weight reduction, 
appetite control and eating behaviour in a group of obese men and women. The 
results showed that, in the group of women, the consumption of this microorgan-
ism provides beneficial effects on mood and behaviour linked to dietary intake, 
compared to the group of men and those who received the placebo. This opens up 
a series of possibilities for health professionals with regard to the implementation 
of successful obesity programmes, especially considering that many individuals 
experience great difficulties when trying to sustain their weight loss. This is mainly 
due to poor appetite control and not taking the necessary action to lead a healthy 
lifestyle. Based on the findings of this research, it has been suggested that some 
probiotic strains could be included as environmental factors with regard to body 
weight loss and maintenance [27].
Corroborating these findings, a multicentre, randomised, double-blind study 
conducted on 29 men and 14 women, using the microorganism Lactobacillus gasseri 
and administered through a probiotic yogurt for 12 weeks, demonstrated, in the 
individuals analysed, a 4.6% decrease in areas of abdominal and subcutaneous fat, 
as well as a decrease in BMI, waist and hip circumference [4].
Nevertheless, and contrary to these results, several investigations using a similar 
model maintain that administering yogurt with other species of probiotics such as 
Figure 3. 
Gut microbiota imbalance between healthy and obese individuals.
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Bacillus lactis Bb 12 and Lactobacillus acidophilus La5 has no effect on body weight, 
BMI and serum lipid levels. This is also the case with Streptococcus thermophilus in 
fermented milk for 8 weeks [4].
As previously mentioned, the impact of consuming probiotics in relation to 
obesity and a variety of parameters has been widely documented. This is, thanks to 
studies on rats, used when administering different strains of the Lactobacillus and 
Bifidobacterium genera; various hypotheses have emerged from these investiga-
tions. More specifically, one of these arose from observing axenic mice (without 
gut microbiota). Despite consuming 30% more food than conventional animals 
of the same age and weight, they have 42% less total body fat. However, once the 
microbiota from conventional mice was transplanted into the digestive tract of the 
axenic mice, these latter experienced a 57% increase in total body fat. The mecha-
nism associated with this increase is linked to the increased activity of the enzyme 
lipoprotein lipase, which inhibits the fasting-induced adipocyte factor (FIAF) 
hormone due to the effect of the gut microbiota. This explains why axenic mice do 
not show weight gain even when consuming a high-calorie diet. Various studies 
carried out on rats show that the ‘antiobesity’ effect is determined by differences 
between microbial species and strains [20].
There is not much research on the effect of probiotics and their relationship 
with obesity; however, the findings that are available indicate that the changes 
caused by gut microbiota could be useful as another strategy in the current quest to 
combat obesity. However, it is necessary to continue researching in this area, with 
more emphasis on investigations on humans and populations with a representative 
number of subjects so that results can be valid and extrapolated.
7. Discussion
Currently, obesity is a major public health problem worldwide. There is no spe-
cific cause that determines the development of this disease; on the contrary, it is the 
result of numerous factors that interact, including genetic, environmental, food, 
lifestyles, etc. [27]; however, the study of intestinal microbiota and its implication 
in obesity has aroused curiosity among scientists. The current information obtained 
comes mainly from the work done in rats and, exceptionally, in humans [17].
Although much of the research indicates that there are differences in the com-
position of the intestinal microbiota of obese and normal subjects, there is still 
controversy about it [4].
As indicated in this chapter, the development of these intestinal bacterial com-
munities depends to a large extent on the host and can be modified by exogenous 
and endogenous influences. Ghosh et al. in 2011 talked about the direct relationship 
between food patterns and the microbiota composition [18].
In 2013, Devaraj et al. established the existing association in the imbalance of 
the microbiota where the composition of this is affected producing an increase 
of the Firmicutes genus and a decrease of the Bacteroidetes; this instability would 
affect the metabolism of the human being and as a consequence the appearance of 
various metabolic diseases among which obesity stands out [21]. In the same way, 
several publications continue confirming this situation, for example, the study of 
Jameel Barkat of the year 2018 relates the role of the microbiota in the regulation of 
energy balance, food absorption and its relationship with the appearance of various 
diseases: diabetes, metabolic syndrome and obesity, among others [30]. A study 
was conducted in 36 adults analysing the faecal bacterial composition, finding a 
decrease in Firmicutes and Clostridia in diabetic patients compared to the control 
group. This same research reaffirms that among the factors that alter the stability 
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and composition of the microbiota are the changes in the diet (high-fat diets) that 
impact on the relationship between Firmicutes and Bacteroidetes [31].
In order to demonstrate the aforementioned, it is convenient to point out two 
investigations carried out in 2015; Kasai et al. [32] conducted a study in Japanese 
population where they observed that bacterial diversity was significantly higher in 
obese subjects than in nonobese subjects. In the first group, there was a decrease of 
the Bacteroidetes species and increase of Firmicutes [31]. Angelakis et al. showed in 
a study performed in thin and obese subjects that the Firmicutes and Actinobacteria 
genera were the most predominant of the duodenal microbiota; however, in subjects 
with obesity, a higher proportion of anaerobic and lower proportions of aerobic 
genus were observed [33].
On the other hand, there are other authors such as Murugesan et al. that indicate 
in a study carried out in 190 Mexican children between 9 and 11 years old no signifi-
cant differences between the different bacterial species of microbiota in the differ-
ent evaluated subjects [34]. The same happens in Hu et al. In 2015, when 134 Korean 
adolescents from 13 to 16 years old were evaluated, no significant differences were 
found between the Bacteroidetes, Firmicutes and Proteobacteria populations [35].
It is widely recognised in the scientific community that diets with high-fat 
content favour the development of resistance to leptin, hyperphagia and therefore 
obesity. A study points out that the inclusion in the diet of the oligofructose prebi-
otic prevents the development of resistance to leptin and hyperphagia in rats; from 
this it is concluded that oligofructose reduces the energy of ingestion, and therefore 
it is suggested that it has the potential for the obesity treatment [36].
On the other hand, the use of probiotics is associated with multiple health ben-
efits, which are highly endorsed by the scientific community. So far, the data that 
associate a specific type of microorganisms with human obesity are not conclusive, 
since they do not say whether it is the microbiota that plays a cause-effect function 
of obesity or whether it is the intestinal microbiota that is modulated in response 
to obesogenic diets and other factors related to the pathogenesis of this condition 
[28–30, 37].
Studies aimed at modulating the gut microbiota to prevent or control the obesity 
of the host, including the use of probiotics, show positive results [25, 30].
With the reviewed bibliographic evidence, it is crucial to highlight the impor-
tance of including the gut microbiota as one of the factors involved in the manage-
ment of obesity; however, more conclusive information must be analysed about it 
evaluating what happens even in other specific groups such as the child population.
8. Conclusions
As has been discussed in this chapter, multiple factors influence the develop-
ment of obesity, including diet, a sedentary lifestyle, selection and an inadequate 
intake of nutrients such as simple carbohydrates and saturated fats. It has also been 
observed that obese individuals and those of a normal weight have different com-
positions of gut microbiota, with some bacterial families more predominate than 
others, which in turn modulates an individual’s energy balance in some way and 
promotes the development of obesity. It has been established that a dietary supply 
of prebiotics and probiotics, for which there is scientific evidence demonstrating 
their benefits, could serve as an additional tool to curb the rising trend of obesity in 
the population.
However, more studies using randomised, double-blind, controlled trials are 
necessary to demonstrate the efficacy of prebiotics and probiotics for the preven-
tion or treatment of overweight and obesity.
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